LONDON (Reuters) - GlaxoSmithKline said on Tuesday it had chosen its head of consumer healthcare, Emma Walmsley, as its new chief executive, after several months reviewing internal and external candidates.

FRANKFURT (Reuters) - German drugmaker Bayer said its two best-selling drugs had a higher annual peak sales potential than previously targeted, after the agreed $66 billion takeover of Monsanto stirred criticism it might neglect its pharmaceuticals business.

BISHKEK, Sept 20 (Reuters) - Kyrgyz President Almazbek Atambayev, under investigation for potential heart problems, may return to work after Oct. 1, his office said on Tuesday, playing down concerns about the 60-year-old leader's health.

HAVANA (Reuters) - Iran's President Hassan Rouhani met with his Cuban counterpart Raul Castro on Monday in Havana to reaffirm friendly ties between the two countries and express a commitment to deepening their collaboration, Cuban state media reported.

SAN FRANCISCO, Sept 16 (Thomson Reuters Foundation) - G reater support from the public, governments and investors is needed to boost the work of entrepreneurs using business for social good, said industry activists and organizers after a Thomson Reuters Foundation poll highlighted these as key issues.

(Reuters Health) - Sleep irregularities may be tied to a variety of health problems, such as diabetes and obesity, that can increase the risk of cardiovascular disease, a leading U.S. doctors group says.

(Reuters Health) - When children under 12 commit suicide, they are more likely to have a diagnosis of attention deficit disorder than depression, a U.S. study suggests.

(Reuters) - Bowing to pressure from patient advocates, the U.S. Food and Drug Administration on Monday approved a treatment for Duchenne muscular dystrophy even though an outside panel of experts and the agency's own reviewers questioned the drug's efficacy.

(Reuters Health) - Codeine isn’t safe for children and shouldn’t be used to ease pain or relieve coughs, a leading U.S. pediatricians group warns.